A reversible or sometimes irreversible biological process where the continuous or excessive presence of a hormone or ligand causes a reduction in the target cell’s responsiveness to that signal, despite adequate circulating levels. This phenomenon, also known as downregulation, occurs due to biochemical modifications or a reduction in the number of functional receptors on the cell surface. Desensitization is a key mechanism of hormonal resistance and is a clinical challenge in both endogenous endocrine disorders and exogenous hormone therapy.
Origin
This concept is fundamental to molecular endocrinology and pharmacology, emerging from the study of cellular communication and the mechanisms of tolerance to drugs and hormones. The term combines “receptor site,” the specific binding location, with “desensitization,” the loss of sensitivity. It explains why constant stimulation can lead to a diminished biological effect.
Mechanism
The mechanism often begins with receptor phosphorylation, which tags the receptor for internalization into the cell’s interior, a process called endocytosis. Once internalized, the receptors may be dephosphorylated and recycled back to the membrane, or they may be degraded in the lysosome, leading to a net reduction in surface receptor density. This reduction requires a higher concentration of the hormone to elicit the same response, effectively dampening the signal transduction efficiency.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.